|1.||She, Yi-Min: 1 article (12/2013)|
|2.||Cheng, Keding: 1 article (12/2013)|
|3.||Farnsworth, Aaron: 1 article (12/2013)|
|4.||Cyr, Terry D: 1 article (12/2013)|
|5.||Li, Xuguang: 1 article (12/2013)|
|6.||Chevalier, Michel: 1 article (11/2011)|
|7.||Nicolaï, Marie-Claire: 1 article (11/2011)|
|8.||Krell, Tino: 1 article (11/2011)|
|9.||Vogel, Fred: 1 article (11/2011)|
|10.||Lancelot, Eloïse: 1 article (11/2011)|
|1.||Human Influenza (Influenza)
06/30/2006 - "However, optimal influenza-specific MBC activation was T cell-independent when MBCs were simply cultured with beta-propiolactone (BPL)-inactivated influenza virus particles (BPL-flu). "
12/01/2013 - "Surface modifications of influenza proteins upon virus inactivation by β-propiolactone."
10/01/1990 - "Influenza antigens inactivated with 1.7 Mrad displayed comparable potency, sensitivity, specificity and stability to those inactivated by standard procedures with beta-propiolactone (BPL). "
11/02/2006 - "Clinical trials with nasal vaccines consisting of beta-propiolactone inactivated influenza particles, showed that it was possible to achieve serum concentrations of antibodies at levels providing protection against influenza. "
03/01/2010 - "Successful heat inactivation coincided with the loss of hemagglutinin (HA) and neuraminidase (NA) characteristics, and beta-propiolactone inactivation reduced the hemagglutination titer and NA activity of the human influenza virus 10-fold or more. "
01/01/1982 - "The hepatitis risk of protein fractions derived from pooled human plasma is eliminated by beta-propiolactone treatment and UV irradiation. "
11/01/1988 - "beta-propiolactone (beta-PL) treatment has been evaluated for its ability to inactivate 10(3.5) chimpanzee infectious doses (CID50) of the Hutchinson strain of hepatitis non-A, non-B virus (HNANBV). "
02/01/1985 - "In order to ensure its hepatitis safety, the starting plasma is cold sterilized by beta-propiolactone and UV-irradiation. "
04/01/1964 - "PROPIOLACTONE PLUS ULTRAVIOLET-TREATED PLASMA WITHOUT HEPATITIS. "
01/01/1962 - "Serum hepatitis and the clinical evaluation of blood components sterilized with beta-propiolactone."
05/01/1972 - "Newcastle disease vaccination with beta-propiolactone-inactivated virus given intratracheally."
01/01/1966 - "Comparison of a beta-propiolactone whole embryo Newcastle disease vaccine (one strain) with a beta-propriolactone amino-allantoic Newcastle disease vaccine (four strain)."
08/01/1969 - "Immunization of chickens against Newcastle disease with beta-propiolactone-killed virus antigen administered in drinking water."
07/01/1969 - "Comparison of a beta-propiolactone inactivated four-strain with three single-strain Newcastle disease vaccines."
01/30/1965 - "COMPARATIVE EVALUATION OF THE POTENCY OF BETA-PROPIOLACTONE INACTIVATED NEWCASTLE DISEASE VACCINES PREPARED FROM A LENTOGENIC STRAIN AND A VELOGENIC STRAIN."
05/01/1972 - "The vaccine prepared by ionizing radiation was equal or superior to that prepared by beta-propiolactone in its ability to protect mice from rabies infection. "
01/01/1978 - "In a field trial 181 high risk persons of both sexes between ages of 2--71 years were prophylactically vaccinated against rabies with the beta-propiolactone inactivated rabies-vaccine (hdc) mrc-5. "
12/01/2004 - "BRP batch 4 and batch 3 are all freeze-dried vaccines prepared by beta-propiolactone inactivation of the Pitman Moore strain of rabies. "
03/01/1997 - "The antidiphtherial and anti-rabies sera treated with beta-propiolactone and pepsin presented protein purity levels of 5,698 and 7,179 Lf/g, 16,233 and 6,784 IU/g, respectively. "
08/01/1990 - "Peripheral blood leucocytes (PBL) from unvaccinated dogs and dogs vaccinated subcutaneously with beta-propiolactone (BPL) inactivated sheep brain antirabies vaccine were exposed in vitro to rabies antigen. "
|5.||Venezuelan Equine Encephalomyelitis
07/01/1961 - "Studies were made comparing the toxicity of beta-propiolactone (BPL) for mammalian (mouse) cells in vitro and for mice and for Venezuelan equine encephalomyelitis (VEE) virus which is highly cytopathogenic for each. "
07/01/1961 - "Comparative effects of beta-propiolactone on mice, mouse-derived cell cultures, and Venezuelan equine encephalomyelitis virus."
07/01/1959 - "I. Effect of beta-propiolactone vapor on Venezuelan equine encephalomyelitis virus."
|4.||Rabies Vaccines (Rabies Vaccine)
|5.||Immunoglobulin M (IgM)
|9.||DNA (Deoxyribonucleic Acid)
|1.||Homologous Transplantation (Allograft)